Sep 08, 2023
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.56 to $0.02.
The split itself did not change the total investment value.
Spyre Therapeutics, Inc. (SYRE) trades on the NASDAQ Capital Market in the Biotechnology industry.
Spyre Therapeutics, Inc. company overviewThe latest split shown was on September 8, 2023. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records one reverse split, on September 8, 2023.